MedPath

Metaverse-Based Healthy Life Program for Youth

Not Applicable
Not yet recruiting
Conditions
Healthy Nutrition
Health Risk Behaviors
Non Communicable Diseases
Health-Related Behavior
Physical Inactivity
Healthy Eating Index
Healthy Lifestyle
Stress, Emotional
Interventions
Behavioral: MetaHealth Group
Behavioral: MobileHealth Group
Registration Number
NCT05332886
Lead Sponsor
Ayşegül İşler Dalgıç
Brief Summary

This study was planned within the scope of the call titled "Non-communicable diseases risk reduction in adolescence and youth (Global Alliance for Chronic Diseases - GACD)" with identity number HORIZON-HLTH-2022-DISEASE-07-03. The purpose of this project; is to determine the effect of the Metaverse-Based Healthy Life Program to be developed in the project to support youths in decreasing future risks of developing non-communicable diseases (NCDs) and in gaining healthy lifestyle behaviors (HLBs).

Detailed Description

The project consists of three phases. Phase 1 Testing the content, quality, reliability, and usability of the "Metaverse-Based Healthy Life Program for Youth" to be developed within the scope of the project Phase 2 Identifying youth at high risk of chronic non-communicable diseases in the research population Phase 3 Evaluating the effect of "Metaverse-Based Healthy Life Program for Youth" implementation on inculcating healthy lifestyle behaviors in youth

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
600
Inclusion Criteria
  • Being a university student in the project partner countries and not older than 24,
  • Having a score of 130 or lower on the HLBS II in the first stage of the research,
  • Determining that BMI ≥ 25-34.99 kg/m2 in the first stage of the research and
  • Using a smartwatch during the research,
  • Accepting to participate in the research voluntarily
Exclusion Criteria
  • Having chronic diseases (asthma, diabetes, heart, kidney failure, hypertension, cancer, etc.)
  • Those who have a drug that they use constantly
  • Having a psychiatric diagnosis (depression, anxiety, bipolar disorder, schizophrenia, etc.)
  • Having a disease that prevents the use of metaverse (vertigo, vision, hearing, etc.)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
MetaHealth GroupMetaHealth GroupIt is intervention group that aims to provide youth with healthy lifestyle behaviors by using metaverse technology.
MobileHealth GroupMobileHealth GroupIt is comparator group that aims to provide youth with healthy lifestyle behaviors by using mobile application materials with digital health education will be given to the MobileHealth Group.
Primary Outcome Measures
NameTimeMethod
Healthy Lifestyle Behavior Scale II (HLBS II)The HLBS II score will evaluate at sixth month

The HLBS II consists of 52 items in total and has 6 sub-factors. Sub-factors are spiritual growth, health responsibility, physical activity, nutrition, interpersonal relationships, and stress management. All items on the scale are positive. The rating is in the form of a 4-point Likert. Never (1), sometimes (2), often (3), regularly (4). The lowest score for the whole scale is 52, and the highest score is 208. The Cronbach Alpha reliability coefficient of the scale is 0.94.

International Physical Activity Questionnaire-Short Form (IPAQ-SF)The IPAQ-SF score will evaluate at sixth month

The IPAQ-SF is a standardized questionnaire prepared to measure the physical activity of people between the ages of 15 and 65. In the survey, there are 7 questions in total in 4 separate sections about the activities that have been done for a minimum of 10 minutes in the last 7 days. The results obtained in the assessment are calculated as metabolic equivalent task (MET) - min/week.

Positive and Negative Affect Schedule (PANAS-SF)The PANAS-SF score will evaluate at sixth month

The PANAS-SF is a self-report questionnaire that consists of two 10-item scales to measure both positive and negative affect. Each item is rated on a 5-point scale of 1 (not at all) to 5 (very much).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Aysegul ISLER DALGIC

🇹🇷

Antalya, Konyaaltı, Turkey

© Copyright 2025. All Rights Reserved by MedPath